Literature DB >> 18763811

Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules.

Katherine L Germane1, Ryoma Ohi, Marcia B Goldberg, Benjamin W Spiller.   

Abstract

VirA, an essential virulence factor in Shigella disease pathogenesis, is involved in the uptake, motility, and cell-to-cell spread of Shigella organisms within the human host. These functions have been attributed to a VirA protease activity and a mechanism of microtubule destruction via tubulin degradation [Yoshida, S., et al. (2006) Science 314, 985-989]. We report functional and crystallographic data indicating a novel VirA structure that lacks these activities but highlights the homology to the EspG virulence factor of pathogenic Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763811      PMCID: PMC4096815          DOI: 10.1021/bi801533k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  A comparison of position-specific score matrices based on sequence and structure alignments.

Authors:  Anna R Panchenko; Stephen H Bryant
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

2.  Evaluation of protein fold comparison servers.

Authors:  Marian Novotny; Dennis Madsen; Gerard J Kleywegt
Journal:  Proteins       Date:  2004-02-01

3.  Adhesion and ultrastructural properties of human enterotoxigenic Escherichia coli producing colonization factor antigens III and IV.

Authors:  S Knutton; M M McConnell; B Rowe; A S McNeish
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

4.  Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens.

Authors:  W Deng; Y Li; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  SCOP: a structural classification of proteins database for the investigation of sequences and structures.

Authors:  A G Murzin; S E Brenner; T Hubbard; C Chothia
Journal:  J Mol Biol       Date:  1995-04-07       Impact factor: 5.469

6.  Measurement of invasion by gentamicin resistance.

Authors:  E A Elsinghorst
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 7.  The anatomy and taxonomy of protein structure.

Authors:  J S Richardson
Journal:  Adv Protein Chem       Date:  1981

8.  EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.

Authors:  S J Elliott; E O Krejany; J L Mellies; R M Robins-Browne; C Sasakawa; J B Kaper
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Transmissible murine colonic hyperplasia.

Authors:  S W Barthold; G L Coleman; R O Jacoby; E M Livestone; A M Jonas
Journal:  Vet Pathol       Date:  1978-03       Impact factor: 2.221

10.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more
  16 in total

1.  The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly.

Authors:  Tara L Archuleta; Yaqing Du; Chauca A English; Stephen Lory; Cammie Lesser; Melanie D Ohi; Ryoma Ohi; Benjamin W Spiller
Journal:  J Biol Chem       Date:  2011-08-13       Impact factor: 5.157

2.  Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.

Authors:  Katherine L Germane; Benjamin W Spiller
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

3.  The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold.

Authors:  Andrey S Selyunin; Sarah E Sutton; Bethany A Weigele; L Evan Reddick; Robert C Orchard; Stefan M Bresson; Diana R Tomchick; Neal M Alto
Journal:  Nature       Date:  2010-12-19       Impact factor: 49.962

4.  EseG, an effector of the type III secretion system of Edwardsiella tarda, triggers microtubule destabilization.

Authors:  Hai Xia Xie; Hong Bing Yu; Jun Zheng; Pin Nie; Leonard J Foster; Yu-Keung Mok; B Brett Finlay; Ka Yin Leung
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

5.  Modulation of host microtubule dynamics by pathogenic bacteria.

Authors:  Girish K Radhakrishnan; Gary A Splitter
Journal:  Biomol Concepts       Date:  2012-12-01

6.  Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri.

Authors:  Jamaine Davis; Jiawei Wang; Joseph E Tropea; Di Zhang; Zbigniew Dauter; David S Waugh; Alexander Wlodawer
Journal:  Protein Sci       Date:  2008-09-11       Impact factor: 6.725

7.  Biochemical and structural insights into microtubule perturbation by CopN from Chlamydia pneumoniae.

Authors:  Agata Nawrotek; Beatriz G Guimarães; Christophe Velours; Agathe Subtil; Marcel Knossow; Benoît Gigant
Journal:  J Biol Chem       Date:  2014-07-23       Impact factor: 5.157

8.  Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.

Authors:  Lila G Glotfelty; Anita Zahs; Kimberley Hodges; Kuangda Shan; Neal M Alto; Gail A Hecht
Journal:  Cell Microbiol       Date:  2014-08-07       Impact factor: 3.715

Review 9.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

10.  Selective protection of an ARF1-GTP signaling axis by a bacterial scaffold induces bidirectional trafficking arrest.

Authors:  Andrey S Selyunin; Lovett Evan Reddick; Bethany A Weigele; Neal M Alto
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.